AstraZeneca’s Tagrisso slashes death risk in certain post-surgery lung cancer patients
LONDON, June 4 (Reuters) - AstraZeneca's lung most cancers remedy, Tagrisso, lower…
Adidas slashes 2022 outlook, investors pin hopes on incoming CEO
Revises down FY working margin to 2.5%FY outlook contains affect from termination…
